Limedix GmbH
PrivateLast Round
Grant
Feb 2, 2026
Total Funding Raised
$1.03M
Company Overview
Limedix GmbH is a health technology company that develops digital speech therapy applications for patients with speech disorders, such as aphasia and articulation disorders.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Vertical SaaS, Telemedicine
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limedix GmbH Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Limedix GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 2, 2026 | ||||
| Grant | Jul 8, 2022 | ||||
| Grant | Nov 18, 2020 | ||||
| Grant | Jul 1, 2017 |
Key People
Founding team and executive leadership
Limedix GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| FilmFernsehFonds Bayern | Grant |
| Friedrich-Alexander-Universität Erlangen-Nürnberg | Grant |
| EIT Health | Grant |
| Federal Ministry for Economic Affairs and Energy | Grant |
| Ludwig-Maximilians-Universität München | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 6, 2025
Grew 30% QoQ, from 10 to 13 employees.
Limedix GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Limedix GmbH's valuation, stock price, and market status.